$AVCRF – Avricore Health Inc., promotional campaign starting Dec 28, 2021 @ 7:04 AM CST

on December 28, 2021 Stock Promotion Tracking and Tags: , , , , , , , , , with 0 comments

Summary

Start time:
7:04 AM
Start date:
December 28, 2021
Symbol:
AVCRF
Company:
Avricore Health Inc.
Stock promoter:
"Stocks To Buy Now"
Stock promoter rank:
25 out of 26
Promoter score:
-1.3
Campaign ID:
36952

Avricore Health Inc.

Market capitalization:
$11,679,032
(as of December 21, 2021)
Floating shares:
89,010,587
(as of November 30, 2021)
Outstanding shares:
97,325,264
(as of December 13, 2021)

Stock Promoter Performance

The following charts displays the first day results for campaigns by "Stocks To Buy Now". Results are taken from a total of 17 stock promotions by this stock promoter that have been tracked by OTC Dynamics.
21% closed down

25% closed up

53% had no net effect

Last 3 Stock Promotions By "Stocks To Buy Now"

Symbol Company Start Date Close Change
AABB Asia Broadband, Inc. December 15, 2021 0.186 -5%
ISWH ISW Holdings Inc. December 8, 2021 1.40 23%
PBIO Pressure BioSciences, Inc. November 30, 2021 2.42 -3%

AVCRF Promotional Newsletter

The following is a newsletter released by "Stocks To Buy Now" promoting Avricore Health Inc.

Caution

The following newsletter has not been verified for accuracy or completeness.

Stocks To Buy Now

Tip of the Week

Avricore Health Inc.
TSX.V AVCR OTCQB AVCRF

Avricore Health Inc. TSX.V OTCQB is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering, HealthTab a wholly owned subsidiary, the company aims to make actionable health information more accessible to everyone by creating the worlds largest network of rapid testing devices in community pharmacies.

HealthTab

HealthTab is a turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs sometimes known as Community Diagnostic Centers, or CDCs and connects them on a single, cloud-based platform.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery and empowers patients to take more control of their health. It also reduces costs and waiting times while providing many potential revenue streams, including equipment leasing consumables, direct access testing, disease prevention management programs, sponsored health programs, decentralized clinical trials, real world data RWD sets and third-party app integration through API.

Investment Considerations

Avricore Health Inc. is a pharmacy solutions provider that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues.
The companys wholly owned subsidiary, HealthTab, offers fast, accurate and cost-effective point-of-care screening.
Its current test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease e.g., HbA1c, Lipid Profile, eGFR HealthTab has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19.
The company leverages strategic partnerships with notable names in the diagnostic space, including Abbott Rapid Diagnostics, to offer high quality, low-cost screening tests.
In June 2021, Avricore announced its master agreement to pilot its HealthTab platform for diabetes management in select Shoppers Drug Mart pharmacies.
Avricores ultimate aim is to make actionable health information more accessible to everyone by creating the worlds largest network of rapid testing devices in community pharmacy.

Recent Coverage

InvestorNewsBreaks - Avricore Health Inc. TSX.V AVCR OTCQB AVCRF Committed to Creating World's Largest Rapid Testing Network in Pharmacy

Avricore Health TSX.V AVCR OTCQB AVCRF, a point-of-care health testing technology innovator, has rolled out its trademarked HealthTabTM platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing their conditions. Avricores purpose is to likewise empower community pharmacies, particularly those in Canada whose revenues were impacted by the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 that reduced retail margins in reimbursements, reads a recent article. Weve demonstrated a unique resilience by remaining focused on our goal of creating the worlds largest rapid testing network in pharmacy, Avricore CEO Hector Bremner stated earlier this year. We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.

To view the full press release, visit

If there is a stock you would like our team to review, let us know

Other Companies We Are Watching

Get Instant Stock Alerts via Text

Ever hear a stock tip too late
Get immediate SMS notification by singing up for GotStockTips

Text stocks to 77948

US Mobile Phones Only

Although this service is free, message and data
rates from carrier may apply. .

Copyright 2010-2017

Get Every Penny Stock Alert!

OTC Dynamics tracks all penny stock promotions. Become a member today and never miss another penny stock promotion!

Sign up today!

Note

OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.

The information on this page is not a recommendation to buy or sell securities.